As of 2025-07-10, the Intrinsic Value of SonoScape Medical Corp (300633.SZ) is 8.93 CNY. This 300633.SZ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 28.52 CNY, the upside of SonoScape Medical Corp is -68.7%.
The range of the Intrinsic Value is 7.18 - 13.31 CNY.
Based on its market price of 28.52 CNY and our intrinsic valuation, SonoScape Medical Corp (300633.SZ) is overvalued by 68.7%.
Range | Selected | Upside | ||
a | ||||
DCF (Growth Exit 5Y) | 7.18 - 13.31 | 8.93 | -68.7% | |
DCF (Growth Exit 10Y) | 9.92 - 19.82 | 12.76 | -55.2% | |
DCF (EBITDA Exit 5Y) | 16.83 - 28.49 | 22.29 | -21.9% | |
DCF (EBITDA Exit 10Y) | 19.33 - 35.56 | 26.53 | -7.0% | |
Peter Lynch Fair Value | 2.91 - 2.91 | 2.91 | -89.81% | |
P/E Multiples | 3.57 - 10.16 | 6.64 | -76.7% | |
EV/EBITDA Multiples | 1.39 - 11.99 | 5.90 | -79.3% | |
Earnings Power Value | 4.81 - 5.54 | 5.18 | -81.8% | |
Dividend Discount Model - Stable | 0.98 - 3.14 | 2.06 | -92.8% | |
Dividend Discount Model - Multi Stages | 9 - 18.06 | 11.63 | -59.2% |
Market Cap (mil) | 12,341 |
Beta | 1.73 |
Outstanding shares (mil) | 433 |
Enterprise Value (mil) | 11,173 |
Market risk premium | 6.6% |
Cost of Equity | 9.8% |
Cost of Debt | 5% |
WACC | 9.7% |